Publications:

Phase 1b trial of isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma.

Cancer

Martin, Thomas G TG; Shah, Nina N; Richter, Joshua J; Vesole, David H DH; Wong, Sandy W SW; Huang, Chiung-Yu CY; Madduri, Deepu D; Jagannath, Sundar S; Siegel, David S DS; Biran, Noa N; Wolf, Jeffrey L JL; Parekh, Samir S; Cho, Hearn J HJ; Munster, Pamela P; Richard, Shambavi S; Ziti-Ljajic, Samira S; Chari, Ajai A

Publication Date: 2021-06-01

Variant appearance in text: HR: K70d

PubMed Link: 33735504

Variant Present in the following documents:

• Main text
• CNCR-127-1816.pdf

View BVdb publication page